Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
203.00    0.40 (0.20%)
Bid:
202.40
Ask:
203.40
Spread: 1.00 (0.494%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Jul 2009 07:00

RNS Number : 7555V
Ashmore Group PLC
16 July 2009
 



 Ashmore Group plc

+0700 16 July 2009 

TRADING UPDATE AND ASSETS UNDER MANAGEMENT sTATEMENT

Ashmore Group plc ("Ashmore", the "Group"), a leading specialist emerging markets asset manager, announces the following trading update and Assets under Management ("AuM") statement in respect of the period ended 30 June 2009.

Assets under Management

Actual 

Estimated 

Estimated

Theme

31 March

2009

(US$ billion)

30 June

2009

(US$ billion)

Movement

Q3vsQ4

(%)

External Debt 

14.4

16.0

+11%

Local Currency

4.6

4.5

-2%

Special Situations

4.4

4.3

-2%

Equity

0.1

0.1

-

Total

23.5

24.9

+6%

The final quarter of the financial year ended 30 June 2009 saw AuM increase by US$1.4 billion (6%) to US$24.9 billion. This increase comprises investment performance of US$1.9 billion, arising in external debt and local currency, partially offset by net redemptions of US$0.5 billion, solely within the local 

currency theme.

During the financial year ended 30 June 2009, AuM decreased to US$24.9 billion from US$37.5 billion. Investment performance was US$5.1 billion adverseUS$7.1 billion adverse in the first half, and US$2.0 billion positive in the second half. Neredemptions in the period were US$7.4 billion, of which US$5.7 billion arose in the first half of the year across all themes, largely reflecting the liquidity needs of our clients in the extreme market conditions. Over the second half, redemptions have slowed significantly, while subscription levels have begun to increase within both public funds and segregated mandates, with net subscriptions achieved in May and June.  

The expansion of the average revenue margin experienced in the first half, principally because of the AuM mix, has been impacted by the timing and make up of external debt and local currency redemptions at the back end of the first half, and through the second half. This has resulted in the average revenue margin for the final quarter returning to the FY07/08 level of 103bps.  

The results for the full year ended 30 June 2009 are in-line with management expectations in the current operating environment. The loss for the year in respect of FX hedge contracts is £42.8 million (6 months to 31 December 2008: £54.2 million)of which £4.5 million (6 months to 31 December 2008: £12.7 million) relates to the mark-to-market of forward contracts to partially hedge FY09/10 management fees. These FY09/10 forward contracts have an aggregate notional value 

of US$120 million, marked at the year end rate of GBP1:1.6458USD. Any future gains or losses on these contracts will arise from deviations from this year end rate.

The Group will announce its results in respect of the financial year to 30 June 2009 on 

15 September 2009. There will be a presentation for analysts at 0900 on that date at the offices of Goldman Sachs at Peterborough Court133 Fleet Street London EC4A 2BB. A copy of the presentation will be made available on the Group's website at www.ashmoregroup.com.

For further information, please contact:

Ashmore Group plc

Graeme Dell, Group Finance Director +44 (0)20 3077 6000

Penrose Financial  +44(0)20 7786 4888 

Gay Collins +44(0)7798 626282

Ashmore@penrose.co.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIFFVLDEIELIA
Date   Source Headline
22nd Oct 20153:01 pmRNSDirectorate Change
22nd Oct 20152:57 pmRNSResult of AGM
15th Oct 20157:00 amRNSTrading Statement
22nd Sep 20154:30 pmRNSDirector/PDMR Shareholding
22nd Sep 20154:30 pmRNSDirector/PDMR Shareholding
22nd Sep 20154:29 pmRNSNotice of AGM
8th Sep 20157:00 amRNSFinal Results
7th Sep 20151:22 pmRNSHolding(s) in Company
19th Aug 20153:54 pmRNSHolding(s) in Company
9th Jul 20157:00 amRNSTrading Statement
23rd Jun 20155:10 pmRNSHolding(s) in Company
11th Jun 20154:29 pmRNSHolding(s) in Company
1st Jun 20154:10 pmRNSHolding(s) in Company
28th May 20154:48 pmRNSHolding(s) in Company
26th May 201510:32 amRNSDirectorate Change
29th Apr 20151:02 pmRNSDirectorate Change
17th Apr 20152:01 pmRNSDirector/PDMR Shareholding
14th Apr 20157:00 amRNSTrading Statement
13th Apr 201511:25 amRNSDirector/PDMR Shareholding
2nd Apr 20152:50 pmRNSHolding(s) in Company
30th Mar 20155:03 pmRNSDirector/PDMR Shareholding
26th Mar 20159:36 amRNSHolding(s) in Company
17th Mar 20155:00 pmRNSDirector/PDMR Shareholding
27th Feb 20155:00 pmRNSDirector/PDMR Shareholding
27th Feb 20153:37 pmRNSHolding(s) in Company
24th Feb 20157:00 amRNSHalf Yearly Report
13th Jan 20157:00 amRNSQ2 AuM Statement
9th Jan 20153:16 pmRNSHolding(s) in Company
5th Dec 20145:38 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:35 pmRNSHolding(s) in Company
24th Nov 20145:22 pmRNSHolding(s) in Company
7th Nov 20148:26 amRNSHolding(s) in Company
30th Oct 20143:08 pmRNSDirectorate Change
30th Oct 20143:04 pmRNSResult of AGM
16th Oct 20143:58 pmRNSDirector/PDMR Shareholding
16th Oct 20143:50 pmRNSHolding(s) in Company
14th Oct 20147:00 amRNSInterim Management Statement
2nd Oct 20143:54 pmRNSDirector/PDMR Shareholding
29th Sep 20142:36 pmRNSNotice of AGM
18th Sep 20145:00 pmRNSDirector/PDMR Shareholding
12th Sep 20144:48 pmRNSDirector/PDMR Shareholding
12th Sep 20144:43 pmRNSHolding(s) in Company
11th Sep 20147:00 amRNSFinal Results
10th Sep 20145:43 pmRNSHolding(s) in Company
9th Sep 20142:39 pmRNSHolding(s) in Company
18th Jul 201410:37 amRNSHolding(s) in Company
10th Jul 20147:00 amRNSQ4 AuM Statement
25th Jun 201411:07 amRNSHolding(s) in Company
28th May 20145:15 pmRNSDirector/PDMR Shareholding
14th Apr 20149:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.